MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$748K
EPS
$0.01
Unit: Thousand (K) dollars

Income Statement
2026-06-30
2026-03-31
2025-12-31
Research and development expenses
--411*
General and administrative expenses
--455*
Intangible asset and goodwill impairment expenses
--2,420*
Operating loss
---3,286*
Financial expense (income), net
--14*
Loss before tax expenses
---3,272*
Research and development expenses
443 473 -
General and administrative expenses
289 266 -
Operating loss
-732 -739 -
Tax expenses
--90*
Financial income, net
-16 14 -
Net loss and comprehensive loss
-748 -725 -3,362
Basic EPS
0.01 0.01 -0.055
Diluted EPS
0.01 0.01 -0.055
Basic Average Shares
60,729,100 60,729,100 60,729,100
Diluted Average Shares
60,729,100 60,729,100 60,729,100
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss andcomprehensive loss-$748K Operating loss-$732K Financial income, net-$16K Research and developmentexpenses$443K General andadministrative expenses$289K

Revium Rx. (RVRC)

Revium Rx. (RVRC)